ScholarWorks@Dongguk University: Kwon, Kyeng hee

Detailed Information

Kwon, Kyeng hee (권경희)

College of Pharmacy (Department of Pharmacy)

Research Area

Tel 031-961-5216
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

HPCIA:3||규제과학:2||Package Leaflet:2||Plain Packaging:2||CIA:2||금연 정책:2||사용량:2||drug:2||THC:2||Regulatory affairs:2||CBD:2||Medication adherence:2||antimicrobials:2||PCU:2||Pharmacist:2||플레인 패키징:2||regulation:2||항생제:2||GMP:2||highest important critically antimicrobials:2||Readability:2||critically important antimicrobials:2||의약품:2||Continuing Professional Development (CPD):1||Controlled drugs:1||Costutility analysis:1||Counseling:1||Cytotoxicity:1||Defined Daily Dose:1||Delphi study:1||Delphi survey:1||Disgust:1||Drug Information:1||Drug approval:1||Drug interaction:1||Drug utilization review:1||ELabel:1||Ecigarette:1||Ecigarettes:1||Education system:1||Emission factor:1||Evaluation:1||FCTC:1||FDA:1||FSPTCA:1||Fear Appeal:1||Febrile neutropenia:1||Fecal microbiota transplantation:1||Fentanyl buccal tablet:1||Flavoring:1||Food Regulatory Science:1||Food safety policy:1||Framework Act on Food Safety:1||Gene therapy:1||Good Manufacturing Practices:1||Graphic Warning Label:1||HPCIAs:1||Hemp:1||Hospital pharmacy:1||Hospital setting:1||Human Resources in Regulatory Science:1||Humanistic approach:1||ICH Q8:1||Job satisfaction:1||Key words: tobacco control:1||Knowledge:1||Lactate dehydrogenase leakage assay:1||Live biotherapeutics product:1||Lowyield cigarette:1||Mainstream smoke chemistry:1||Marijuana:1||Market exclusivity:1||Medical Cannabis Use:1||Medical product:1||Menthol:1||Mentor pharmacist:1||Microbiomebased therapeutics:1||Mixture risk assessment:1||Monitoring:1||Narrative medicine:1||Needs assessment:1||New classification systems:1||Nicotine:1||Opioid dependence:1||PIC/S:1||Patent life:1||Patent term extension:1||Patientcentered Care:1||Pegfilgrastim:1||Pegteograstim:1||Pharmacist specialty certificate:1||Pharmacists:1||Pharmacist’s role:1||Population Correction Unit:1||Product Labeling:1||Protein adsorption:1||Q10:1||Q9:1||Reactive oxygen species:1||Recurrence:1||Regulation:1||Regulatory Science:1||Regulatory Science Innovation:1||Regulatory science:1||Republic of Korea:1||Research & Development Programs:1||Risk factor:1||Rural areas:1||Safer management:1||Selfevaluation:1||Shortages of pharmacists:1||Silver nanoparticles:1||Support for Commercialization:1||The office manager's hospital:1||Tobacco:1||Tobacco Control:1||Tools:1||UK. Japan:1||Ulcerative colitis:1||United States:1||Vaping:1||Virus vector:1||Vividness Effect:1||Wholesalers:1||adverse drug events:1||animal:1||antismoking policy:1||antibiotics:1||clinical study of advanced regenerative medicine:1||companion animals:1||compounding preparation:1||conditions of use:1||definiteness:1||discourse competition:1||dispensing:1||distinction.:1||drug shortage information:1||drug shortage list:1||drug shortages:1||druginduced acute pancreatitis:1||evidencebased regulations:1||extended release:1||foodproducing animals:1||health right:1||human antibiotics:1||human medicine:1||illegal hospital:1||ingredient and emissions:1||investigator initiated trial:1||kickbacks:1||label:1||labeling:1||law:1||legibility:1||marketing order:1||medical technology:1||medicine:1||medicines:1||menthol:1||nonprescription drug:1||opioid analgesic:1||pain management:1||pharmacist:1||pharmacovigilance:1||polypharmacy:1||population correction unit:1||post marketing studies:1||practice:1||premarket tobacco applications(PMTA):1||prereview:1||prescription:1||quality by design:1||quality risk management:1||readability:1||research and development strategy:1||safety management:1||sales:1||scoring:1||splitting:1||stem cell therapy:1||the Medical Service Act:1||the National Medical Insurance Act:1||the special judicial police officers authority:1||tobacco products:1||trend:1||usage:1||veterinarian prescription system:1||가족흡연예방 및 담배 규제법(FSPTCA):1||가축:1||건강보험법:1||공포소구:1||국민건강권:1||국민건강보험의 재정누수:1||궐련 개비:1||규제:1||규제과학 전문인력 양성:1||규제과학혁신:1||규제업무:1||근거 중심의 규제:1||금연의도:1||담론 경쟁:1||담배:1||담배 개비:1||담뱃갑:1||담뱃갑 경고그림:1||대마:1||동물:1||리베이트:1||마리화나:1||마케팅 승인:1||명확성의 원칙:1||무광고 표준담뱃갑:1||미국 식품의약국(FDA):1||반려동물:1||법령:1||보건권:1||불법개설기관:1||사용 조건:1||사전검토:1||설계기반 품질고도화(QbD):1||수의사 처방제:1||시판 전 승인 명령(PMTA):1||시판 후 임상시험:1||안전상비의약품:1||연구 및 발전 전략:1||연구개발사업:1||의료기술:1||의료법:1||의료용 대마사용:1||의료제품:1||의약품 제조 및 품질관리기준(GMP):1||의약품 품질리스크관리(QRM):1||인체용 의약품:1||인체용 항생제:1||임상연구:1||재생의료:1||전자담배:1||제품 라벨링:1||제품화 지원:1||조제:1||주제어: 담배 제품 규제:1||줄기세포치료:1||처방:1||첨단재생바이오법:1||판매량:1||표시:1||항균제:1||행위구별.:1||헴프:1||혐오:1||AAV:1||흡연기피 의도:1||Act on Regulatory Science Innovation:1||Adenoassociated virus:1||Advanced regenerative bio act:1||Adverse drug event:1||Aerosol:1||Affect as Spotlight:1||Breast cancer:1||Canada:1||Cannabis:1||Capsule:1||Cardiovascular patients:1||Cigarette:1||Cigarette Packaging:1||Cigarette Stick:1||Cigarettes:1||Clinical design:1||Clostridioses difficile:1||Commercial eliquids:1||Common Technical Document:1||Competency:1||Compliance:1||Compulsory rural service:1||

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE